Know this sz Flashcards

1
Q

Valproate

A

Efficacy

Broad spectrum agent with efficacy against the most common seizure types

Pharmacokinetics

Administered as enteric-coated and delayed-release formulations

Inhibits metabolism of other AEDs: phenytoin, lamotrigine, carbamazepine, phenobarbital, ethosuximide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dose-related GI upset (nausea-vomiting, pain)

Weight gain common

Black Box Warnings

  • Hepatic failure
  • Life-threatening pancreatitis – monitor symptoms
  • Teratogenic effects (neural tube defects) – weigh benefit-risk
A

Valproate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Status Epilepticus Treatment Options:

A

Initial therapy IV diazepam (lorazepam or midazolam) until seizures stop or 20 mg given

Then start phenytoin or fosphenytoin slow infusion

If seizures persist IV phenobarbital until seizures stop

If seizures still continue, pentobarbital or propofol infusion with pressor support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Drug of choice in absence seizures

A

Ethosuximide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ethosuximide

A

Adverse Drug Reactions – generally few side effects

Dose-related gastric distress most common (NV, pain)

Less common: transient lethargy-fatigue, dizziness, headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanism - Efficacy

Precise mechanism unknown - affects Ca++ channels

1st line in treatment of generalized tonic-clonic seizures

A

Levetiracetam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Levetiracetam ADRs

A

Somnolence, asthenia, dizziness

Low incidence of cognitive effects

No CYP450 metabolism - minimal DDIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Effects on VSSCs (suppress repetitive APs) and VSCCs (↓ Glu release) - broad spectrum

1st line for partial or generalized seizures - better tolerated than phenytoin or carbamazepine

A

Lamotrigine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ADRs Lamotrigine

A

Similar to phenytoin (lower incidence): diplopia, ataxia, dizziness, skin rashes, sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Phenytoin

A

Very effective against partial and tonic-clonic seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Phenytoin Pharmacokinetics

A

Oral absorption is formulation dependent – concern with generic switching

IM absorption erratic (better with prodrug Fosphenytoin)

Zero-order (saturation) metabolism in therapeutic range

**Strong inducer of CYP450 enzymes –> DDIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Phenytoin Adverse Drug Reactions

A

Nystagmus-diplopia-ataxia-sedation –> dose-related

Rash; gingival hyperplasia-hirsutism develop gradually

Long-term use –> osteomalacia, peripheral neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Carbamazepine Efficacy

A

A drug of choice for partial seizures

Often tried first in tonic-clonic seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Carbamazepine Pharmacokinetics

A

**Strong inducer of CYP450 enzymes –> self-induction + drug-drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Carbamazepine Adverse Drug Reactions

A

Diplopia-ataxia-sedation –> dose-related

GI upset

Rare but serious

Aplastic anemia-agranulocytosis –> monitor CBC

Hepatotoxicity –> monitor liver function tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

________ and phenobarbital enhance the inhibitory effect of GABA (↑ opening of Cl- channels)

A

Benzodiazepines

Valproate appears to act partly by this mechanism

17
Q

A drug of choice for partial seizures

Often tried first in tonic-clonic seizures

A

Carbamazepine

18
Q

Diplopia-ataxia-sedation –> dose-related

GI upset

Rare but serious

Aplastic anemia-agranulocytosis –> monitor CBC
Hepatotoxicity –> monitor liver function tests

A

Carbamazepine

19
Q

Strong inducer of CYP450 enzymes –>
self-induction + drug-drug interactions

Pharmacokinetics

A

Carbamazepine

20
Q

Initial therapy IV diazepam (lorazepam or midazolam) until seizures stop or 20 mg given

Then start phenytoin or fosphenytoin slow infusion

If seizures persist IV phenobarbital until seizures stop

If seizures still continue, pentobarbital or propofol infusion with pressor support

A

Status Epilepticus

21
Q

Neonatal status epilepticus

Adjunct for partial and tonic-clonic seizures

A

Phenobarbital

22
Q

Metabolized slowly by P450 system - t1/2 of 4-5 days

Classic enzyme inducer

A

Phenobarbital

23
Q

Irritability - overactivity in many children, sedative effects in others

Mild ataxia, nystagmus, skin rash, osteomalacia

May interfere with learning (cognitive deficits)

A

Phenobarbital

24
Q

A drug of choice for partial seizures

Often tried first in tonic-clonic seizures

A

Carbamazepine

25
Q

Decrease in low-threshold Ca++ (T-type) current

A

Oscillatory currents in thalamic neurons are abnormal in absence seizures - blocked by ethosuximide-valproate

26
Q

Inhibition of high-voltage activated Ca++-channels

A

VSCC (aka N-type) involved in regulation of glutamate neurotransmitter release - lamotrigine

27
Q

Inhibits function of synaptic vesicle protein SV2A

A

Impairs Ca++-mediated neurotransmitter release - levetiracetam

28
Q

________ –> block excitation of cells firing repetitively (epileptic foci) leaving low frequency firing neurons (normal) unaffected

A

Blockade is use-dependent

Phenytoin, carbamazepine, lamotrigine, valproate

29
Q

Inhibition of Sodium Channel Function

A

Block sustained high-frequency repetitive firing of APs that can initiate seizure formation

Phenytoin, carbamazepine, lamotrigine, valproate

30
Q

Impairs Ca++-mediated neurotransmitter release - levetiracetam

A

Inhibits function of synaptic vesicle protein SV2A